Get the tools used by (smart)2 investors.

Diluted EPS CAGR (7y)

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

1.00
Price
Fair Value
Upside
0.98 - 7.79
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on 's Diluted EPS CAGR (7y):

INZYHLTH.USAIMDCDNAWINTOLMAVCNX5.0%6.0%7.0%8.0%

Performance Summary
  • Diluted eps cagr (7y) for Inozyme Pharma Inc is not meaningful. While computing the change, we detected that the latest value is negative, making the calculation not meaningful.

How does Inozyme's Diluted EPS CAGR (7y) benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Inozyme Pharma Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: Diluted EPS CAGR (7y)

Hide this widget
eps_diluted_cagr_7y
Slug
number
Datatype
text
Format
current
Default Period
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Diluted EPS CAGR (7y) in the growth category include:

View Full List

Search for metric or datapoint

Diluted EPS CAGR (7y)

Seven-year compound annual growth rate in diluted EPS.

Definition of Diluted EPS CAGR (7y)

Hide this widget

Diluted EPS CAGR (7y) measures the seven-year compound annual growth rate in Diluted EPS Incl Extra Items.

Compound annual growth rate (CAGR) is a commonly used business and investing term that measures the growth of a metric over multiple periods. CAGRs are useful since they reduce the effect of volatility in specific periods, unlike arithmetic means.

Growth calculations are always made in the company’s reporting currency to ensure currency fluctuations do not impact the calculation. Inozyme Pharma’s reports in the USD currency. You can read more about Diluted EPS Incl Extra Items here and compound annual growth rate on Wikipedia. You may also find variants three-year Diluted EPS Incl Extra Items CAGR, and five-year Diluted EPS Incl Extra Items CAGR useful.


Click the link below to download a spreadsheet with an example Diluted EPS CAGR (7y) calculation for Inozyme Pharma Inc below:

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-29.2%-4.2%20.8%68.2%0204060

The chart above depicts the distribution of diluted eps cagr (7y) for companies operating in the Healthcare sector in the Developed economic region. Over 400 companies were considered in this analysis, and 388 had meaningful values. The average diluted eps cagr (7y) of companies in the sector is 5.4% with a standard deviation of 14.5%.

Inozyme Pharma Inc's Diluted EPS CAGR (7y) of NM- ranks in the - percentile for the sector. The following table provides additional summary stats:

Diluted EPS CAGR (7y) In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents404
Included Constituents388
Min-32.9%
Max63.3%
Median4.8%
Mean5.4%
Standard Deviation14.5%

You can find companies with similar diluted eps cagr (7y) using this stock screener.

All rights reserved. Terms Of Use